Correlation Between Milestone Pharmaceuticals and Kaleido Biosciences
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Kaleido Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Kaleido Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Kaleido Biosciences, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Kaleido Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Kaleido Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Kaleido Biosciences.
Diversification Opportunities for Milestone Pharmaceuticals and Kaleido Biosciences
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Milestone and Kaleido is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Kaleido Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kaleido Biosciences and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Kaleido Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kaleido Biosciences has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Kaleido Biosciences go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Kaleido Biosciences
If you would invest 1.00 in Kaleido Biosciences on November 2, 2024 and sell it today you would earn a total of 0.00 from holding Kaleido Biosciences or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 5.26% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Kaleido Biosciences
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Kaleido Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Milestone Pharmaceuticals and Kaleido Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Kaleido Biosciences
The main advantage of trading using opposite Milestone Pharmaceuticals and Kaleido Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Kaleido Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kaleido Biosciences will offset losses from the drop in Kaleido Biosciences' long position.The idea behind Milestone Pharmaceuticals and Kaleido Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Kaleido Biosciences vs. Inhibikase Therapeutics | Kaleido Biosciences vs. Tempest Therapeutics | Kaleido Biosciences vs. CytomX Therapeutics | Kaleido Biosciences vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |